Consensus Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
18.87 CNY -0.68% Intraday chart for Pharmaron Beijing Co., Ltd. -2.63% -34.89%

Evolution of the average Target Price on Pharmaron Beijing Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

0224ca7b027d7256f8ea7.lOgYsHc0UWV2H12XoeGjvnp3VveJUltgsDzb21GoRnk.4Jkp_gJuJlQacmTc2YXH0AA7EbnmagElg1DothjsCkvV2U-DEmU1XAxzMg~fbee9e390ede7af593d5a3f87cf1de13
Nomura Adjusts Pharmaron Beijing’s Price Target to HK$17.99 From HK$30.92, Keeps at Buy MT
Nomura Adjusts Pharmaron’s Price Target to 61.24 Yuan From 66.94 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron’s Price Target to 66.94 Yuan From 73.38 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron’s Price Target to HK$36.24 From HK$40.03, Keeps at Buy MT
Nomura Adjusts Pharmaron’s Price Target to 73.38 Yuan From 85.63 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron's Price Target to HK$60.04 From HK$69.02, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to 85.63 Yuan From 90.01 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to HK$69.02 From HK$62.19, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to 90.01 Yuan From 99.95 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to HK$62.19 From HK$91.89, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to 99.95 Yuan From 103.74 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to HK$91.89 From HK$94.89, Keeps at Buy MT
UBS Adjusts Pharmaron’s Price Target to HK$149 From HK$240, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to HK$141.62 From HK$178.52, Keeps at Buy MT
Nomura Adjusts Pharmaron's Price Target to 154.84 Yuan From 203.32 Yuan, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
18.87 CNY
Average target price
25.78 CNY
Spread / Average Target
+36.61%
High Price Target
40 CNY
Spread / Highest target
+111.98%
Low Price Target
9.1 CNY
Spread / Lowest Target
-51.78%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Pharmaron Beijing Co., Ltd.

Nomura
UBS
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock Market
  2. Equities
  3. 300759 Stock
  4. Consensus Pharmaron Beijing Co., Ltd.